BioCentury
ARTICLE | Emerging Company Profile

Grace: seeking cures in pathological roots

Grace Science hopes to parlay discovery of rare disease target into therapies for orphan, non-orphan diseases

August 16, 2019 12:38 AM UTC

Grace Science is targeting the root of a recently discovered genetic disorder for not just the ultra-rare condition but also for common diseases including cancer.

Grace Science LLC’s origins stem from the diagnosis of co-founder and CEO Matt Wilsey’s daughter Grace with NGLY1 deficiency in 2013...